DNA Q1 2023 Earnings — Ginkgo Bioworks Holdings, Inc. Revenue & Financial Results | Market Cap Arena

DNAGinkgo Bioworks Holdings, Inc.

$418M

Q1 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$81M-52.1% YoY

Gross Profit

$58M72.3% margin

Operating Income

-$216M-267.3% margin

Net Income

-$205M-254.0% margin

EPS (Diluted)

$-4.29

QoQ Revenue Growth

-17.9%

Cash Flow

Operating Cash Flow

-$91M

Free Cash Flow

-$110M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$2.4B

Total Liabilities

$810M

Stockholders' Equity

$1.6B

Cash & Equivalents

$1.2B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$81M	$168M	-52.1%
Gross Profit	$58M	$83M	-29.7%
Operating Income	-$216M	-$675M	+68.1%
Net Income	-$205M	-$591M	+65.3%

Revenue Segments

Service

$35M75%

Product

$12M25%